Trial Profile
A retrospective case series assessing treatment response to H.P. Acthar Gel in patients with nephrotic syndrome.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Mar 2016
Price :
$35
*
At a glance
- Drugs Corticotropin (Primary)
- Indications Nephrotic syndrome
- Focus Therapeutic Use
- 04 Mar 2016 New trial record